Neven P, Stahl N, Vidal M, Martin M, et al. A preoperative window-of-opportunity study of oral SERD, imlunestrant, in newly diagnosed ER-positive, HER2-negative early breast cancer: Results from EMBER-2 Study. Clin Cancer Res 2024 Oct 8. doi: 10.1158/1078-0432.CCR-24-2113.
PMID: 39377773